Hong Kong has taken a monumental step forward in expanding its global economic footprint. Last week, Chief Executive John Lee Ka-chiu, leading a high-level business delegation, wrapped up a successful five-day mission to Kazakhstan and Uzbekistan. This historic visit – marking the first time the chief executive has led a mission to Central Asia – yielded 96 cooperation agreements and memorandums of understanding valued at more than US$1.65 billion. The exceptional results signal a major pivot...

Stock Market Today, June 8: Marvell, Intel, and Micron Lead Tech Stock Rebound The Globe and Mail

Elon Musk's SpaceX is on the verge of launching the largest initial public offering (IPO) in history. For years, everyday investors were forced to watch IPOs from the sidelines, as offering prices were almost exclusively reserved for large financial institutions and high-net-worth clients. Retail investors chased IPO stocks once they hit the public exchanges -- often buying shares at inflated prices and missing the real upside. Fidelity recently lowered its eligibility requirement for the SpaceX IPO to those who hold a modest $2,000 balance in their account. This is a dramatic shift from the traditional six-figure minimums imposed by legacy brokerages. On the surface, this might look like a win for small investors. However, a closer look at the mechanics of IPOs raises some legitimate questions about who really benefits from increased retail participation. Continue reading

The filing comes a little more than a week after its main rival, Anthropic, also filed to go public, ramping up the race between the two AI firms.

Today, June 8, 2026, investors are parsing Apple’s new AI ecosystem push to gauge its impact on future device demand.

Apple (NASDAQ:AAPL), maker of smartphones, computers, tablets, and other services, closed Monday at $301.54, down 1.89%. The stock initially moved as high as about $317 per share as investors reacted to WWDC 2026 disclosures around a next-generation AI-powered Siri, the new “Appl

ChatGPT开发商OpenAI于周一秘密提交了美国首次公开募股（IPO）申请，与竞争对手Anthropic一道进军股市，以满足投资者对人工智能热潮的投资需求。 OpenAI未披露此次发行的规模或条款，但有报道称，这家人工智能巨头计划在最早可能于9月进行的首次公开募股中，争取高达1万亿美元的估值。 若估值如期达成，OpenAI将开启三家万亿估值公司接连上市的序幕，这也被视为近十年来对投资者对高增长科技股兴趣的最关键考验。 埃隆·马斯克旗下的SpaceX率先启动了IPO进程，若成功完成，这将是有史以来规模最大的IPO，该公司计划以1.75万亿美元的估值募集750亿美元资金。 在交易者对未来事件结果进行押注的预测市场上，大多数参与者原本预计OpenAI会在Anthropic之前提交IPO申请。 人工智能时代 Anthropic和OpenAI的IPO将标志着科技行业和全球市场一个变革时期的到来，人工智能正迅速成为本十年的核心投资主题。 OpenAI今年早些时候表示，正以8400亿美元估值从 软银 9984.T、 亚马逊 AMZN.O和英伟达NVDA.O等重量级投资者处筹集1100亿美元。 当时，该公司还披露，ChatGPT的周活跃用户已超过9亿，消费者订阅用户超过5000万。 此次IPO申请是在OpenAI与其早期投资者之一 微软 MSFT.O重新协商合作关系之后进行的，此次重新协商使这家AI先驱得以与亚马逊和Alphabet旗下GOOGL.O的 谷歌 等公司建立新的合作伙伴关系。 这家Windows系统制造商自2019年以来的早期投资总额达130亿美元，为OpenAI的快速崛起铺平了道路，同时也推动了这家软件巨头Azure云计算业务的增长。 今年3月，OpenAI表示其月营收已达20亿美元，增长速度约为定义互联网和移动时代的公司的四倍，其中包括Alphabet和MetaMETA.O。 相比之下，2024年底其季度营收约为10亿美元。 挑战者势头正盛 然而，OpenAI开创的这一行业已迅速变得竞争激烈，包括Anthropic在内的竞争对手正争相挑战其主导地位，而投资者则密切关注人工智能行业的迅猛崛起能否持续。 Anthropic已崭露头角，成为最大的竞争对手之一，其ClaudeAI因能协助软件开发者处理编程任务而需求激增，部分企业更部署其顶级模型Mythos来挖掘代码中的...

SpaceX disclosed a cloud service agreement with Google covering about 110,000 NVIDIA GPUs at its Memphis data centers, adding to a separate $1.25 billion monthly Anthropic deal.

Apple's (AAPL) annual Worldwide Developers Conference (WWDC) kicks off on Monday at the iPhone maker's headquarters, where the company unveiled its new AI-powered Siri (or Siri AI). Yahoo Finance Tech Editor Dan Howley reports live from Cupertino, CA, to share the biggest takeaways from the 2026 WWDC. This is Tim Cook's final WWDC as Apple CEO before he steps down this September, transitioning into an executive chairman role.

tigerstrawberry/iStock via Getty Images Emergent BioSolutions Inc. ( EBS ) was founded in 1998 and is based in Gaithersburg, MD. It describes itself as ‘a global life sciences company focused on providing innovative preparedness and response solutions addressing accidental, deliberate, and naturally occurring Public Health Threats.’ Emergent has 11 products, with its business spread across three distinct segments: Commercial products, consisting of Narcan 4mg nasal spray and Kloxxado 8mg nasal spray to treat opioid (esp. fentanyl) overdosing; Medical counter-measures (MCM) products, consisting of vaccines and treatments for Anthrax and Smallpox, predominantly, alongside also Mpox, Botulism, and Ebola; Bioservices offerings. The revenue split across all three is outlined below for Q1 2026 revenues. Data from 10-Q Comparing Q1 2025 to Q1 2026, total revenue fell from $222.2 million to $156.1 million. All three segments experienced declines in revenue y/y. The fall in MCM revenue was the most dramatic in terms of total dollar amounts. Data from 10-Q With the stock down over 40% from a recent high and 94% from its all-time high, investors may be inclined to pick up shares in hopes of a turnaround. I was bearish in my last article , calling it a “value trap,” but the stock has rebounded by 55% since then. Seeking Alpha In this article, I’ll offer my thoughts on the price action and discuss their two main revenue drivers: Naloxone and MCM. I’ll discuss the former first, as it was the strongest part of their business, by which I mean it declined by the lowest percentage compared to the others. The Naloxone Business Segment As a reminder, Narcan is the well-known brand name of the naloxone nasal spray that provides an emergency life-saving response to opioid overdose, not just for fentanyl but also for heroin, oxycodone (OxyContin), hydrocodone (Vicodin), codeine, and morphine. Emergent acquired the rights to Narcan nasal spray in 2018, and it received FDA approval to be su...

【有線新聞】內地有人用智能眼鏡偷拍空中服務員後，將片段放上品牌專頁「分享」，引起爭議。涉事智能眼鏡品牌聲稱，已下架所有違規內容，強調已緊急啟動專項整改。 上海一名女子在一個智能眼鏡品牌的官方程式專頁內，發現有人發布在飛機上偷拍空姐的照片及影片，還附帶不當內容貼文。除了空中服務員，亦有其他不同場景的偷拍影片，對象包括路人、地鐵乘客等。 用來拍攝的智能眼鏡本身設有拍攝提示燈，以保護被拍者，但有購物平台出售的所謂「遮光貼」，能有效遮蔽提示燈令人幾乎無法察覺，眼鏡品牌官網亦未有任何相關提醒，造成漏洞。智能眼鏡品牌方作出回應，強調已緊急啟動專項整改，全面下架所有違規內容，嚴肅處理違規賬號，並承諾整頓升級監管機制。針對惡意規避安全機制的「提示燈遮光貼」，品牌方已正式向各銷售平台發起投訴，同時會繼續研發新品，升級硬件防護。 有法律界人士提醒，未經他人同意在公眾場合偷拍他人，並發布至互聯網，已明確侵犯他人肖像權和私隱權，被侵權人有權要求停止侵害並賠償損失。至於售賣規避設備隱私提示的「遮光貼」，涉及為潛在的違法侵權行為提供便利，商家及平台都可能需要承擔法律責任。

The company's CEO sounded a cautious note about consumers at an industry conference that month.

Key PointsThe stock was also hit with a pair of analyst price target cuts.

Intel Corporation Shs -CAD hedged- Canadian Depositary Receipt Repr Shs Reg S Trade Ideas — LSX:A3DQG5 TradingView

标普500指数周一上涨，收复上周部分跌幅，芯片股大涨，同时投资者评估中东紧张局势缓和的影响。 标普500指数上涨0.3%。上周五，强劲就业数据推动市场提高对美联储加息的预期，导致该指数大跌 纳斯达克 100指数上涨1.6%，创逾一周来最大涨幅，主要受半导体板块带动 费城半导体指数上涨5.6%； 美光 科技上涨近10%，博通上涨2.8% 英特尔 上涨11%，创5月8日以来最大单日涨幅，此前The Information报道称， 谷歌 将2028年逾300万颗专用AI芯片订单交给英特尔 但美股尾盘回吐部分涨幅，市场广度依然疲弱，彭博汇编数据显示，标普500指数成分股中逾320只下跌，仅180余只上涨 11个行业板块中有8个收跌，公用事业、房地产和原材料板块跌幅居前。 等权重标普500指数基本持平，显示除芯片股外市场整体表现偏弱。 债券交易员预计，本周公布的通胀数据将显示消费者价格显著上涨，从而进一步加大美联储加息压力。 美国消费者价格数据将于周三公布;美联储官员已进入6月17日利率决议前的静默期。 “逢低买入资金回归，但仅收复了上周五行情调整的一部分，”Navellier & Associates首席投资官Louis Navellier表示。“伊朗局势仍是主要地缘政治风险”。 美股科技七巨头指数基本持平，尽管英伟达上涨1.7%。 除芯片股外，多数大型科技股下跌。 苹果 下跌1.9%，投资者对其下一代人工智能平台反应平淡。 衡量华尔街恐慌情绪的VIX波动率指数周一回落至约19； 截至收盘，标普500指数上涨0.3%，报7405.73点； 道琼斯 工业平均指数下跌0.2%，报50786.01点； 纳斯达克综合指数上涨0.9%，报25929.66点； 纳斯达克100指数上涨1.6%，报29414.26点； 罗素2000指数上涨0.8%，报2855.424点。 责任编辑：李桐

Strongest earthquake in nearly 150 years hits off Cuba, shakes Mexico, Florida Reuters

【有線新聞】美國聯邦法官裁定，總統特朗普將引入高技術人才的H-1B簽證申請費用，提高至10萬美元的政策違法，指費用本質是稅收，而徵稅權力在國會而非總統手上。特朗普批評法官的裁決瘋狂，對國家造成損害。 美國總統特朗普去年9月簽署公告，將引入外國高技術專業人才的H-1B工作簽證費用提高至10萬美元，比原來的費用高20至50倍，觸發20名民主黨州檢察長入稟挑戰。 波士頓地區法官索羅金周一就案件頒布42頁書面判詞，裁定措施違法，認同控方指大幅提高H-1B簽證費用無論本質或用途都等同徵稅，不認為是辯方所定義的「監管費用」，或引用案例中的「罰款」，裁定特朗普政府未經國會授權而徵稅，國務院和公民及移民服務局不得執行政策。 法官又在判詞指，聯邦稅款不一定要經國稅局徵收，並引用最高法院今年2月推翻華府關稅措施的裁決，指由國土安全部徵收的關稅憲法上亦是稅收。 司法部回應裁決，強調華府決心保障美國勞工，全力支持總統的「美國優先」政策，揚言繼續追究濫用H-1B簽證的企業。 H-1B每年有8萬5千個配額，主要分配給矽谷科企聘請外國工程師，前年逾7成申請者來自印度，中國人佔約1成。

美国国债周一收盘下跌，但得益于油价从盘中高点回落，国债跌幅也较盘中收窄。伊朗与以色列之间的战火升级推动油价一度升至盘中高点，但随着袭击停止，油价回落。国债收益率曲线趋陡，上周五因强劲5月份就业报告引发的剧烈趋平幅度在一定程度上逆转。 纽约时间下午3点刚过，整个收益率曲线上升1个基点至3个基点，2年/10年和5年/30年利差分别扩大1.5个基点和2个基点。 10年期收益率接近4.55%，盘中高点为4.58%。 加拿大债券表现逊色，5年/30年利差扩大4.5个基点。 亚马逊 计划发行140亿加元投资级债券，这是有记录以来最大规模的加元计价公司债发行。 WTI原油期货结算价上涨0.8%，此前在伊朗和以色列冲突的刺激下一度上涨5.5%；以色列总理内塔尼亚胡随后表示，如果德黑兰停火，以色列也将暂停对伊朗的打击。 标普500指数收盘上涨0.3%， 纳斯达克 综合指数上涨近0.9%，对人工智能的热情重燃促使逢低买盘涌现。 美东时间下午4点左右 美国2年期国债收益率上涨1.3个基点，报4.1597%； 美国5年期国债收益率上涨2.3个基点，报4.2903%； 美国10年期国债收益率上涨3.6个基点，报4.5661%； 美国30年期国债收益率上涨4.7个基点，报5.0425%； 美国5年和30年期国债收益率差上升约2.5个基点，报75.05个基点。 美国2年和10年期国债收益率差上升约2.5个基点，报40.44个基点。 责任编辑：李桐

Mama's Creations, Inc. (MAMA) delivered earnings and revenue surprises of +66.67% and +1.87%, respectively, for the quarter ended April 2026. Do the numbers hold clues to what lies ahead for the stock?

The space economy extends far beyond SpaceX.

Key PointsRocket Lab offers launch services and growing revenue.

格隆汇6月9日｜OpenAI当地时间周一发表声明：“我们最近秘密提交了S-1文件。我们预计它会泄露，因此直接予以公布。IPO具体时间尚未确定；可能还需要一段时间，因为作为私营公司，有些事情做起来更容易。但这其中涉及一系列复杂的权衡，这份文件让我们在时机成熟时可以选择更快上市"。OpenAI的这份声明表明该公司正寻求从人工智能热潮中分得一杯羹，其竞争对手Anthropic也正在推进上市进程。

Expanding Private Cloud Compute Apple Security Research

The rally gives Intel a foundry boost, with investors watching the reported Google demand and proof that 18A can scale into real revenue.

Intel (NASDAQ:INTC), which designs and manufactures semiconductor products, including CPUs and GPUs, closed Monday at $110.27, up 11.19%. The stock moved higher as reports highlighted a major Google AI chip order and potential foundry roles with Google and Nvidia. Investors are w

OpenAI表示已秘密向美国证券交易委员会提交S-1注册声明草案，但尚未决定首次公开募股的时间。（财联社）

Marvell’s leap into the S&P 500 caps a sharp AI-chip rebound that helped steady U.S. stocks, today, June 8, 2026.

Stock Market Today, June 8: Marvell, Intel, and Micron Lead Tech Stock Rebound Yahoo Finance

S&P 500 (SNPINDEX:^GSPC) rose 0.30% to 7,405.73 and the Nasdaq Composite (NASDAQINDEX:^IXIC) climbed 0.86% to 25,929.66 as tech stocks began to recover from Friday’s rout. The Dow Jones Industrial Average (DJINDICES:^DJI) slipped 0.16% to 50,786.01 as cyclicals lagged.

For the past several years, the market has associated Eli Lilly (NYSE: LLY) with one thing: obesity. Its blockbuster weight-loss drug Zepbound and diabetes treatment Mounjaro have transformed the company, helping drive annual revenue from $34.1 billion in 2023 to more than $65.2 billion in 2025. But it would be foolish to ignore the elephant in the room: What's next after GLP-1 and obesity treatments? Lilly may have just provided part of the answer. Image source: Getty Images. Continue reading